Document is current
Any future updates will be listed below
-
Authors
Labbé, Geneviève M.
Miura, Kazutoyo
Silk, Sarah E.
Gu, Wenjuan
Moon, James E.
Jin, Jing
Payne, Ruth O.
Fay, Michael P.
Dutta, Sheetij
Long, Carole A.
Draper, Simon J. https://orcid.org/0000-0002-9415-1357
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases
Wellcome Trust (106917/Z/15/Z)
Lister Institute of Preventive Medicine (Prize Fellowship)
United States Agency for International Development (VAC054)
- License Information
-
More Information
Article History
Received: 18 February 2019
Accepted: 24 August 2019
First Online: 2 September 2019
Ethics approval and consent to participate
: See “” section above for VAC054 ethics approval—section entitled “”.
: Not applicable.
: SJD is a named inventor on patent applications relating to malaria vaccines and immunization regimens. SD has a patent on the FMP2.1 vaccine antigen.
